Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Exchange Rate Effect for 4 consecutive years, with -$501000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect rose 73.69% to -$501000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $901000.0, a 139.02% increase, with the full-year FY2024 number at $1.2 million, up 99.51% from a year prior.
  • Exchange Rate Effect was -$501000.0 for Q3 2025 at Centessa Pharmaceuticals, down from -$113000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $3.0 million in Q4 2024 to a low of -$1.9 million in Q3 2024.
  • A 4-year average of -$47133.3 and a median of -$120000.0 in 2024 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 701.59% in 2024; the steepest drop was 965.45% in 2024.
  • Centessa Pharmaceuticals' Exchange Rate Effect stood at $722000.0 in 2022, then plummeted by 169.81% to -$504000.0 in 2023, then skyrocketed by 701.59% to $3.0 million in 2024, then plummeted by 116.52% to -$501000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Exchange Rate Effect are -$501000.0 (Q3 2025), -$113000.0 (Q2 2025), and -$1.5 million (Q1 2025).